Assessment of the Budesonid Protective Effects in Patients with Cardio-Respiratory Comorbidity During Coronary Bypassing with Artificial Circulation

The objective: evaluation of the effect of budesonide and low-volume mechanical ventilation (LVMV) on pulmonary volemia, oxygen transport and respiratory biomechanics in patients with concurrent ischemic heart disease (IHD) and chronic obstructive pulmonary disease (COPD) during coronary artery bypa...

Full description

Bibliographic Details
Main Authors: E. A. Sergeev, B. I. Geltser, V. N. Kotelnikov, A. E. Tarasov, V. Yu. Velichkin, A. A. Silaev
Format: Article
Language:Russian
Published: New Terra Publishing House 2022-05-01
Series:Вестник анестезиологии и реаниматологии
Subjects:
Online Access:https://www.vair-journal.com/jour/article/view/645
_version_ 1826566984566833152
author E. A. Sergeev
B. I. Geltser
V. N. Kotelnikov
A. E. Tarasov
V. Yu. Velichkin
A. A. Silaev
author_facet E. A. Sergeev
B. I. Geltser
V. N. Kotelnikov
A. E. Tarasov
V. Yu. Velichkin
A. A. Silaev
author_sort E. A. Sergeev
collection DOAJ
description The objective: evaluation of the effect of budesonide and low-volume mechanical ventilation (LVMV) on pulmonary volemia, oxygen transport and respiratory biomechanics in patients with concurrent ischemic heart disease (IHD) and chronic obstructive pulmonary disease (COPD) during coronary artery bypass grafting (CABG) with artificial circulation (AC).Subjects and Methods. 50 patients with concurrent IHD and COPD were enrolled in the study. During AC, patients of Group I (20 people) received mechanical ventilation with the peak inspiratory pressure of 15 mbar, tidal volume of 3‒4 ml/kg, positive end-expiratory pressure of 5 mbar in combination with inhalation of nebulized budesonide. In Group II (30 people), the similar isolated respiratory support was provided. Pulmonary blood volume, indices of extravascular lung water (EVLW), pulmonary vascular permeability (PVPI), oxygen delivery (DO2I) and consumption (VO2I), oxygen extraction ratio (O2ER), pulmonary shunt fraction (Qs/Qt), oxygenation index were determined. The study consisted of 3 stages: before AC, after its completion and one day after CABG.Results. Before CABG, the EVLW index in all patients exceeded the standard level by 67‒72%. After weaning from AC, it decreased by 23% in Group I and by 8% in Group II. In patients receiving budesonide, PVPI significantly decreased after artificial circulation, while in patients from Group II, it remained unchanged. DO2I and O2ER in all patients were within the reference range, and VO2I was below it with a minimum value in Group II after weaning from AC. In this cohort, the Qs/Qt level was significantly higher, while OI was lower versus patients from Group I. Among patients who received budesonide immediately after AC and 2 hours after it, pulmonary resistance decreased while lung compliance increased. In Group II, those parameters changed oppositely. In Group I, one case of hydrothorax was recorded, and in Group II, 2 patients were diagnosed with polysegmental pneumonia and 2 patients – with pneumothorax. The median duration of mechanical ventilation in the postoperative period made 220 minutes in Group I, and 290 minutes in Group II (p = 0.018).Conclusion. In patients with concurrent IHD and COPD, use of the combination of low-volume mechanical ventilation and inhalation of nebulized budesonide during AC stabilizes the volemic status of the lungs, improves the oxygenating function and respiratory biomechanics in the postperfusion and early postoperative periods of CABG.
first_indexed 2024-03-12T03:32:14Z
format Article
id doaj.art-d43a19dd93b14061b57a27e80eced104
institution Directory Open Access Journal
issn 2078-5658
2541-8653
language Russian
last_indexed 2025-03-14T11:00:20Z
publishDate 2022-05-01
publisher New Terra Publishing House
record_format Article
series Вестник анестезиологии и реаниматологии
spelling doaj.art-d43a19dd93b14061b57a27e80eced1042025-03-02T10:44:36ZrusNew Terra Publishing HouseВестник анестезиологии и реаниматологии2078-56582541-86532022-05-01192233110.21292/2078-5658-2022-19-2-23-31506Assessment of the Budesonid Protective Effects in Patients with Cardio-Respiratory Comorbidity During Coronary Bypassing with Artificial CirculationE. A. Sergeev0B. I. Geltser1V. N. Kotelnikov2A. E. Tarasov3V. Yu. Velichkin4A. A. Silaev5Far Eastern Federal University, VladivostokFar Eastern Federal University, VladivostokFar Eastern Federal University, VladivostokFar Eastern Federal University, VladivostokFar Eastern Federal University, VladivostokFar Eastern Federal University, VladivostokThe objective: evaluation of the effect of budesonide and low-volume mechanical ventilation (LVMV) on pulmonary volemia, oxygen transport and respiratory biomechanics in patients with concurrent ischemic heart disease (IHD) and chronic obstructive pulmonary disease (COPD) during coronary artery bypass grafting (CABG) with artificial circulation (AC).Subjects and Methods. 50 patients with concurrent IHD and COPD were enrolled in the study. During AC, patients of Group I (20 people) received mechanical ventilation with the peak inspiratory pressure of 15 mbar, tidal volume of 3‒4 ml/kg, positive end-expiratory pressure of 5 mbar in combination with inhalation of nebulized budesonide. In Group II (30 people), the similar isolated respiratory support was provided. Pulmonary blood volume, indices of extravascular lung water (EVLW), pulmonary vascular permeability (PVPI), oxygen delivery (DO2I) and consumption (VO2I), oxygen extraction ratio (O2ER), pulmonary shunt fraction (Qs/Qt), oxygenation index were determined. The study consisted of 3 stages: before AC, after its completion and one day after CABG.Results. Before CABG, the EVLW index in all patients exceeded the standard level by 67‒72%. After weaning from AC, it decreased by 23% in Group I and by 8% in Group II. In patients receiving budesonide, PVPI significantly decreased after artificial circulation, while in patients from Group II, it remained unchanged. DO2I and O2ER in all patients were within the reference range, and VO2I was below it with a minimum value in Group II after weaning from AC. In this cohort, the Qs/Qt level was significantly higher, while OI was lower versus patients from Group I. Among patients who received budesonide immediately after AC and 2 hours after it, pulmonary resistance decreased while lung compliance increased. In Group II, those parameters changed oppositely. In Group I, one case of hydrothorax was recorded, and in Group II, 2 patients were diagnosed with polysegmental pneumonia and 2 patients – with pneumothorax. The median duration of mechanical ventilation in the postoperative period made 220 minutes in Group I, and 290 minutes in Group II (p = 0.018).Conclusion. In patients with concurrent IHD and COPD, use of the combination of low-volume mechanical ventilation and inhalation of nebulized budesonide during AC stabilizes the volemic status of the lungs, improves the oxygenating function and respiratory biomechanics in the postperfusion and early postoperative periods of CABG.https://www.vair-journal.com/jour/article/view/645chronic obstructive pulmonary diseasecoronary artery bypass graftingbudesonidelung protectionprotective mechanical ventilation
spellingShingle E. A. Sergeev
B. I. Geltser
V. N. Kotelnikov
A. E. Tarasov
V. Yu. Velichkin
A. A. Silaev
Assessment of the Budesonid Protective Effects in Patients with Cardio-Respiratory Comorbidity During Coronary Bypassing with Artificial Circulation
Вестник анестезиологии и реаниматологии
chronic obstructive pulmonary disease
coronary artery bypass grafting
budesonide
lung protection
protective mechanical ventilation
title Assessment of the Budesonid Protective Effects in Patients with Cardio-Respiratory Comorbidity During Coronary Bypassing with Artificial Circulation
title_full Assessment of the Budesonid Protective Effects in Patients with Cardio-Respiratory Comorbidity During Coronary Bypassing with Artificial Circulation
title_fullStr Assessment of the Budesonid Protective Effects in Patients with Cardio-Respiratory Comorbidity During Coronary Bypassing with Artificial Circulation
title_full_unstemmed Assessment of the Budesonid Protective Effects in Patients with Cardio-Respiratory Comorbidity During Coronary Bypassing with Artificial Circulation
title_short Assessment of the Budesonid Protective Effects in Patients with Cardio-Respiratory Comorbidity During Coronary Bypassing with Artificial Circulation
title_sort assessment of the budesonid protective effects in patients with cardio respiratory comorbidity during coronary bypassing with artificial circulation
topic chronic obstructive pulmonary disease
coronary artery bypass grafting
budesonide
lung protection
protective mechanical ventilation
url https://www.vair-journal.com/jour/article/view/645
work_keys_str_mv AT easergeev assessmentofthebudesonidprotectiveeffectsinpatientswithcardiorespiratorycomorbidityduringcoronarybypassingwithartificialcirculation
AT bigeltser assessmentofthebudesonidprotectiveeffectsinpatientswithcardiorespiratorycomorbidityduringcoronarybypassingwithartificialcirculation
AT vnkotelnikov assessmentofthebudesonidprotectiveeffectsinpatientswithcardiorespiratorycomorbidityduringcoronarybypassingwithartificialcirculation
AT aetarasov assessmentofthebudesonidprotectiveeffectsinpatientswithcardiorespiratorycomorbidityduringcoronarybypassingwithartificialcirculation
AT vyuvelichkin assessmentofthebudesonidprotectiveeffectsinpatientswithcardiorespiratorycomorbidityduringcoronarybypassingwithartificialcirculation
AT aasilaev assessmentofthebudesonidprotectiveeffectsinpatientswithcardiorespiratorycomorbidityduringcoronarybypassingwithartificialcirculation